Literature DB >> 14661100

Homocysteine and oxidative stress.

A F Perna1, D Ingrosso, N G De Santo.   

Abstract

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease (ischemic disease, such as stroke and myocardial infarction, and arterial and venous thrombotic events) in the general population. We can assume that the association is causal, based on the example of homocystinuria, and on the evidence put forward by several basic science and epidemiological studies; however, the results of large intervention trials, which will grant further support to this hypothesis, are not yet available. In addition, the mechanisms underlying this relationship, and also explaining the several toxic effects of homocysteine, related or not to cardiovascular disease, are unclear. Oxidation is one of the most favored postulated mechanisms; others are nitrosylation, acylation, and hypomethylation. Regarding the relative importance of these mechanisms, each of these hold pros and cons, and these are weighed in order to propose a balance of evidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661100     DOI: 10.1007/s00726-003-0026-8

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  49 in total

Review 1.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

2.  Genetic absence of ALOX5 protects from homocysteine-induced memory impairment, tau phosphorylation and synaptic pathology.

Authors:  Jian-Guo Li; Carlos Barrero; Salim Merali; Domenico Praticò
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

3.  Acute myocardial infarction in a young male wrestler: A case report.

Authors:  Hoorak Poorzand; Reza Jafarzadeh Esfehani; Peyman Hosseinzadeh; Mohammad Vojdanparast
Journal:  ARYA Atheroscler       Date:  2015-11

4.  Folic Acid Protects Rat Cerebellum Against Oxidative Damage Caused by Homocysteine: the Expression of Bcl-2, Bax, and Caspase-3 Apoptotic Genes.

Authors:  Hakimeh Koohpeyma; Iran Goudarzi; Mahmoud Elahdadi Salmani; Taghi Lashkarbolouki; Mohammad Shabani
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

Review 5.  Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease.

Authors:  Federico Cacciapuoti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

6.  Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity.

Authors:  Xiao-Qing Tang; Rong-Qian Chen; Ling Dong; Yan-Kai Ren; Piero Del Soldato; Anna Sparatore; Duan-Fang Liao
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

7.  Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.

Authors:  Elena Díaz-Santiago; Luis Rodríguez-Caso; Casimiro Cárdenas; José J Serrano; Ana R Quesada; Miguel Ángel Medina
Journal:  Redox Rep       Date:  2016-05-19       Impact factor: 4.412

Review 8.  Nongenetic risk factors and congenital heart defects.

Authors:  Sonali S Patel; Trudy L Burns
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

9.  Effect of cysteine dosage on erythrocyte glutathione synthesis rate in a patient with cystathionine beta synthase deficiency.

Authors:  S N van der Crabben; F A Wijburg; M T Ackermans; H P Sauerwein
Journal:  J Inherit Metab Dis       Date:  2008-01-24       Impact factor: 4.982

10.  Homocysteine is a potent modulator of plasma membrane electron transport systems.

Authors:  Javier Rodríguez-Alonso; Raúl Montañez; Luis Rodríguez-Caso; Miguel Angel Medina
Journal:  J Bioenerg Biomembr       Date:  2008-01-24       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.